Biocryst Pharmaceuticals (BCRX) Other Non-Current Liabilities (2014 - 2019)

Biocryst Pharmaceuticals has reported Other Non-Current Liabilities for 4 years, with the latest figure at $3.5 million in Q3 2019.

• For the quarter ending Q3 2019, Other Non-Current Liabilities changed N/A year-over-year to $3.5 million; the trailing twelve-month figure through Sep 2019 stood at $3.5 million (changed N/A YoY), and the FY2018 full-year result was $2.7 million, changed N/A from the prior year.
• Other Non-Current Liabilities for Q3 2019 stood at $3.5 million, down from $3.7 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $3.9 million in Q1 2019, with the low at $974000.0 in Q2 2016.
• Historically, Other Non-Current Liabilities has averaged $2.8 million across 3 years, with a median of $3.1 million in 2018.